S&P 500NASDAQ-100

Amgen (AMGN) — 10-Year DCF Projection Model

Free stock research tool. Build a 10-year revenue, earnings (EPS), and free cash flow forecast for Amgen (AMGN) stock, a company in the Health Care (Biotechnology) sector. Pulls audited SEC EDGAR XBRL financials, triangulates Wall Street analyst consensus across Yahoo Finance, NASDAQ, and StockAnalysis, and overlays AI-clustered news + social event probabilities directly onto projected EPS. For equity research — not personal budgeting or accounting.

Build AMGN projection model →Browse all stocks

Amgen at a glance

Ticker
AMGN
Company
Amgen
Sector
Health Care
Sub-industry
Biotechnology
Headquarters
Thousand Oaks, California
Founded
1980
Added to S&P 500
1992-01-02
Index membership
S&P 500, NASDAQ-100

What you'll see in your AMGN model

  • 10 years of audited historical financials for Amgen, sourced directly from the SEC's EDGAR XBRL filings (10-K and 10-Q).
  • Triangulated Wall Street consensus for AMGN's forward revenue, EBITDA, and EPS across Yahoo Finance, NASDAQ, and StockAnalysis with cross-source dispersion (σ).
  • AI Event Factors: top-10 news/social themes for AMGN with probability sliders and live EPS impact.
  • Sensitivity tables and Excel export for every assumption.

About Amgen

Amgen (NYSE/NASDAQ: AMGN) was founded in 1980 and is headquartered in Thousand Oaks, California. The company operates in the Health Care sector (Biotechnology sub-industry) and is a constituent of the S&P 500 and NASDAQ-100. Our projection model builds a clean discounted-cash-flow view of Amgen in roughly five seconds and lets you adjust every assumption to test your own thesis.